Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Functional and Anatomical Relationships Between the Medial Precentral Cortex, Dorsal Striatum, and Head Direction Cell Circuitry. I: Recording Studies.

Mehlman ML, Winter SS, Valerio S, Taube J.

J Neurophysiol. 2018 Nov 14. doi: 10.1152/jn.00143.2018. [Epub ahead of print]

PMID:
30427767
2.

Functional and Anatomical Relationships Between the Medial Precentral Cortex, Dorsal Striatum, and Head Direction Cell Circuitry. II: Neuroanatomical Studies.

Mehlman ML, Winter SS, Taube JS.

J Neurophysiol. 2018 Nov 14. doi: 10.1152/jn.00144.2018. [Epub ahead of print]

PMID:
30427743
3.

PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.

Ariës IM, Bodaar K, Karim SA, Chonghaile TN, Hinze L, Burns MA, Pfirrmann M, Degar J, Landrigan JT, Balbach S, Peirs S, Menten B, Isenhart R, Stevenson KE, Neuberg DS, Devidas M, Loh ML, Hunger SP, Teachey DT, Rabin KR, Winter SS, Dunsmore KP, Wood BL, Silverman LB, Sallan SE, Van Vlierberghe P, Orkin SH, Knoechel B, Letai AG, Gutierrez A.

J Exp Med. 2018 Nov 7. pii: jem.20180570. doi: 10.1084/jem.20180570. [Epub ahead of print]

PMID:
30404791
4.

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL.

Kang H, Sharma ND, Nickl CK, Devidas M, Loh ML, Hunger SP, Dunsmore KP, Winter SS, Matlawska-Wasowska K.

Biomark Res. 2018 Aug 23;6:27. doi: 10.1186/s40364-018-0141-z. eCollection 2018.

5.

How eating behavior, food stimuli and gender may affect visual attention - An eye tracking study.

Hummel G, Ehret J, Zerweck I, Winter SS, Stroebele-Benschop N.

Eat Behav. 2018 Dec;31:60-67. doi: 10.1016/j.eatbeh.2018.08.002. Epub 2018 Aug 10. No abstract available.

PMID:
30142551
6.

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.

Winter SS, Dunsmore KP, Devidas M, Wood BL, Esiashvili N, Chen Z, Eisenberg N, Briegel N, Hayashi RJ, Gastier-Foster JM, Carroll AJ, Heerema NA, Asselin BL, Gaynon PS, Borowitz MJ, Loh ML, Rabin KR, Raetz EA, Zweidler-Mckay PA, Winick NJ, Carroll WL, Hunger SP.

J Clin Oncol. 2018 Oct 10;36(29):2926-2934. doi: 10.1200/JCO.2018.77.7250. Epub 2018 Aug 23.

PMID:
30138085
7.

Assessing Healthspan and Lifespan Measures in Aging Mice: Optimization of Testing Protocols, Replicability, and Rater Reliability.

Sukoff Rizzo SJ, Anderson LC, Green TL, McGarr T, Wells G, Winter SS.

Curr Protoc Mouse Biol. 2018 Jun;8(2):e45. doi: 10.1002/cpmo.45.

PMID:
29924918
8.

High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL.

Perez DR, Nickl CK, Waller A, Delgado-Martin C, Woods T, Sharma ND, Hermiston ML, Loh ML, Hunger SP, Winter SS, Chigaev A, Edwards B, Sklar LA, Matlawska-Wasowska K.

SLAS Discov. 2018 Aug;23(7):732-741. doi: 10.1177/2472555218774248. Epub 2018 May 10.

PMID:
29746793
9.

Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.

Burns MA, Liao ZW, Yamagata N, Pouliot GP, Stevenson KE, Neuberg DS, Thorner AR, Ducar M, Silverman EA, Hunger SP, Loh ML, Winter SS, Dunsmore KP, Wood B, Devidas M, Harris MH, Silverman LB, Sallan SE, Gutierrez A.

Leukemia. 2018 Oct;32(10):2126-2137. doi: 10.1038/s41375-018-0097-x. Epub 2018 Mar 20.

10.

Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG).

Gupta S, Devidas M, Loh ML, Raetz EA, Chen S, Wang C, Brown P, Carroll AJ, Heerema NA, Gastier-Foster JM, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, Winter SS, Winick NJ, Carroll WL, Hunger SP, Borowitz MJ, Wood BL.

Leukemia. 2018 Jun;32(6):1370-1379. doi: 10.1038/s41375-018-0039-7. Epub 2018 Feb 23.

11.

Dynamic re-immunization of off-treatment childhood cancer survivors: An implementation feasibility study.

Han JH, Harmoney KM, Dokmeci E, Torrez J, Chavez CM, Cordova de Ortega L, Kuttesch JF, Muller M, Winter SS.

PLoS One. 2018 Feb 1;13(2):e0191804. doi: 10.1371/journal.pone.0191804. eCollection 2018.

12.

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.

Bride KL, Vincent TL, Im SY, Aplenc R, Barrett DM, Carroll WL, Carson R, Dai Y, Devidas M, Dunsmore KP, Fuller T, Glisovic-Aplenc T, Horton TM, Hunger SP, Loh ML, Maude SL, Raetz EA, Winter SS, Grupp SA, Hermiston ML, Wood BL, Teachey DT.

Blood. 2018 Mar 1;131(9):995-999. doi: 10.1182/blood-2017-07-794214. Epub 2018 Jan 5.

PMID:
29305553
13.

Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials.

Burke MJ, Devidas M, Maloney K, Angiolillo A, Schore R, Dunsmore K, Larsen E, Mattano LA Jr, Salzer W, Winter SS, Carroll W, Winick NJ, Loh ML, Raetz E, Hunger SP, Bleyer A.

Leuk Lymphoma. 2018 Jul;59(7):1624-1633. doi: 10.1080/10428194.2017.1397658. Epub 2017 Nov 8.

14.

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.

Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, Zhou X, Ma X, Sioson E, Li Y, Rusch M, Gupta P, Pei D, Cheng C, Smith MA, Auvil JG, Gerhard DS, Relling MV, Winick NJ, Carroll AJ, Heerema NA, Raetz E, Devidas M, Willman CL, Harvey RC, Carroll WL, Dunsmore KP, Winter SS, Wood BL, Sorrentino BP, Downing JR, Loh ML, Hunger SP, Zhang J, Mullighan CG.

Nat Genet. 2017 Aug;49(8):1211-1218. doi: 10.1038/ng.3909. Epub 2017 Jul 3.

15.

JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.

Delgado-Martin C, Meyer LK, Huang BJ, Shimano KA, Zinter MS, Nguyen JV, Smith GA, Taunton J, Winter SS, Roderick JR, Kelliher MA, Horton TM, Wood BL, Teachey DT, Hermiston ML.

Leukemia. 2017 Dec;31(12):2568-2576. doi: 10.1038/leu.2017.136. Epub 2017 May 9.

16.

Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia.

Kinjyo I, Matlawska-Wasowska K, Chen X, Monks NR, Burke P, Winter SS, Wilson BS.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26604. Epub 2017 Apr 27.

PMID:
28449314
17.

Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

Erasmus MF, Matlawska-Wasowska K, Kinjyo I, Mahajan A, Winter SS, Xu L, Horowitz M, Lidke DS, Wilson BS.

Sci Signal. 2016 Nov 29;9(456):ra116.

18.

Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.

Mayfield JR, Czuchlewski DR, Gale JM, Matlawska-Wasowska K, Vasef MA, Nickl C, Pickett G, Ness SA, Winter SS.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26328. Epub 2016 Nov 15.

19.

CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS.

Oruganti SR, Torres DJ, Krebsbach S, Asperti-Boursin F, Winters J, Matlawska-Wasowska K, Winter SS, Halsey C, Cannon JL.

Leukemia. 2017 Jan;31(1):255-258. doi: 10.1038/leu.2016.272. Epub 2016 Oct 4. No abstract available.

20.

The medial frontal cortex contributes to but does not organize rat exploratory behavior.

Blankenship PA, Stuebing SL, Winter SS, Cheatwood JL, Benson JD, Whishaw IQ, Wallace DG.

Neuroscience. 2016 Nov 12;336:1-11. doi: 10.1016/j.neuroscience.2016.08.041. Epub 2016 Aug 31.

PMID:
27590266
21.

Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.

Perez DR, Smagley Y, Garcia M, Carter MB, Evangelisti A, Matlawska-Wasowska K, Winter SS, Sklar LA, Chigaev A.

Oncotarget. 2016 Jun 7;7(23):33960-82. doi: 10.18632/oncotarget.8986.

22.

MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.

Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey RC, Nickl CK, Ness SA, Rusch M, Li Y, Onozawa M, Martinez C, Wood BL, Asselin BL, Chen IM, Roberts KG, Baruchel A, Soulier J, Dombret H, Zhang J, Larson RS, Raetz EA, Carroll WL, Winick NJ, Aplan PD, Loh ML, Mullighan CG, Hunger SP, Heerema NA, Carroll AJ, Dunsmore KP, Winter SS.

Leukemia. 2016 Sep;30(9):1909-12. doi: 10.1038/leu.2016.60. Epub 2016 Mar 8. No abstract available.

23.

RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines.

Ksionda O, Melton AA, Bache J, Tenhagen M, Bakker J, Harvey R, Winter SS, Rubio I, Roose JP.

Oncogene. 2016 Jul 14;35(28):3658-68. doi: 10.1038/onc.2015.431. Epub 2015 Nov 9.

24.

Passive Transport Disrupts Grid Signals in the Parahippocampal Cortex.

Winter SS, Mehlman ML, Clark BJ, Taube JS.

Curr Biol. 2015 Oct 5;25(19):2493-502. doi: 10.1016/j.cub.2015.08.034. Epub 2015 Sep 17.

25.

Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434.

Winter SS, Dunsmore KP, Devidas M, Eisenberg N, Asselin BL, Wood BL, Leonard Rn MS, Murphy J, Gastier-Foster JM, Carroll AJ, Heerema NA, Loh ML, Raetz EA, Winick NJ, Carroll WL, Hunger SP.

Pediatr Blood Cancer. 2015 Jul;62(7):1176-83. doi: 10.1002/pbc.25470. Epub 2015 Mar 8.

26.

Spatial navigation. Disruption of the head direction cell network impairs the parahippocampal grid cell signal.

Winter SS, Clark BJ, Taube JS.

Science. 2015 Feb 20;347(6224):870-874. doi: 10.1126/science.1259591. Epub 2015 Feb 5.

27.

The evaluation of thioridazine as a hematopoietic progenitor cell mobilizing agent in healthy human subjects.

Chigaev A, Sklar LA, Schrader R, Stephens N, Raissy H, Winter SS.

J Clin Pharmacol. 2015 May;55(5):512-6. doi: 10.1002/jcph.448. Epub 2015 Feb 4. No abstract available.

28.

Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis.

Di Pierro E, Russo R, Karakas Z, Brancaleoni V, Gambale A, Kurt I, Winter SS, Granata F, Czuchlewski DR, Langella C, Iolascon A, Cappellini MD.

Eur J Haematol. 2015 Jun;94(6):491-7. doi: 10.1111/ejh.12452. Epub 2014 Oct 25.

PMID:
25251786
29.

Pyrosequencing for classification of human FcγRIIIA allotypes: a comparison with PCR-based techniques.

Matlawska-Wasowska K, Gale JM, Nickl CK, Khalili P, Shirley B, Wilson BS, Vasef MA, Winter SS.

Mol Diagn Ther. 2014 Dec;18(6):665-73. doi: 10.1007/s40291-014-0120-5.

PMID:
25230857
30.

ATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia.

Winter SS, Ricci J, Luo L, Lovato DM, Khawaja HM, Serna-Gallegos T, Debassige N, Larson RS.

Health (Irvine Calif). 2013 May;5(5A). doi: 10.4236/health.2013.55A005.

31.

Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.

Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, Harvey RC, Govern C, Bakker J, Lenstra TL, Ammon K, Boeter A, Winter SS, Loh M, Shannon K, Chakraborty AK, Wabl M, Roose JP.

Sci Signal. 2013 Mar 26;6(268):ra21. doi: 10.1126/scisignal.2003848.

32.

Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.

Di Cello F, Dhara S, Hristov AC, Kowalski J, Elbahloul O, Hillion J, Roy S, Meijerink JP, Winter SS, Larson RS, Huso DL, Resar L.

Leuk Lymphoma. 2013 Aug;54(8):1762-8. doi: 10.3109/10428194.2013.764422. Epub 2013 Feb 1.

PMID:
23311322
33.

Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.

Matlawska-Wasowska K, Ward E, Stevens S, Wang Y, Herbst R, Winter SS, Wilson BS.

Leukemia. 2013 Jun;27(6):1263-74. doi: 10.1038/leu.2013.5. Epub 2013 Jan 11.

34.

Analysis of movement kinematics on analogous spatial learning tasks demonstrates conservation of direction and distance estimation across humans (Homo sapiens) and rats (Rattus norvegicus).

Köppen JR, Winter SS, Loda EL, Apger BP, Grimelli D, Hamilton DA, Wallace DG.

J Comp Psychol. 2013 May;127(2):179-93. doi: 10.1037/a0030162. Epub 2012 Oct 22.

PMID:
23088648
35.

Limbic system structures differentially contribute to exploratory trip organization of the rat.

Winter SS, Köppen JR, Ebert TB, Wallace DG.

Hippocampus. 2013 Feb;23(2):139-52. doi: 10.1002/hipo.22075. Epub 2012 Oct 4.

PMID:
23034954
36.

Infusion of GAT1-saporin into the medial septum/vertical limb of the diagonal band disrupts self-movement cue processing and spares mnemonic function.

Köppen JR, Winter SS, Stuebing SL, Cheatwood JL, Wallace DG.

Brain Struct Funct. 2013 Sep;218(5):1099-114. doi: 10.1007/s00429-012-0449-7. Epub 2012 Aug 19.

PMID:
22903287
37.

Serial pattern learning during skilled walking.

Wallace DG, Winter SS, Metz GA.

J Integr Neurosci. 2012 Mar;11(1):17-32.

PMID:
22744781
38.

High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

Wu D, Sherwood A, Fromm JR, Winter SS, Dunsmore KP, Loh ML, Greisman HA, Sabath DE, Wood BL, Robins H.

Sci Transl Med. 2012 May 16;4(134):134ra63. doi: 10.1126/scitranslmed.3003656.

39.

Drug Repurposing from an Academic Perspective.

Oprea TI, Bauman JE, Bologa CG, Buranda T, Chigaev A, Edwards BS, Jarvik JW, Gresham HD, Haynes MK, Hjelle B, Hromas R, Hudson L, Mackenzie DA, Muller CY, Reed JC, Simons PC, Smagley Y, Strouse J, Surviladze Z, Thompson T, Ursu O, Waller A, Wandinger-Ness A, Winter SS, Wu Y, Young SM, Larson RS, Willman C, Sklar LA.

Drug Discov Today Ther Strateg. 2011 Winter;8(3-4):61-69.

40.

Recommendations for broader coverage antifungal prophylaxis in childhood acute myeloid leukemia: ASH evidence-based review 2011.

Gramatges MM, Winter SS.

Hematology Am Soc Hematol Educ Program. 2011;2011:374-6. doi: 10.1182/asheducation-2011.1.374. Review.

PMID:
22160060
41.

Pediatric acute leukemia therapies informed by molecular analysis of high-risk disease.

Winter SS.

Hematology Am Soc Hematol Educ Program. 2011;2011:366-73. doi: 10.1182/asheducation-2011.1.366. Review.

PMID:
22160059
42.

Is prolonged stem cell mobilization detrimental for hematopoiesis?

Chigaev A, Winter SS, Sklar LA.

Med Hypotheses. 2011 Dec;77(6):1111-3. doi: 10.1016/j.mehy.2011.09.015. Epub 2011 Oct 2.

43.

The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.

Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen SC, Zhang J, Protopopov A, Chin L, Dahlberg SE, Neuberg DS, Silverman LB, Winter SS, Hunger SP, Sallan SE, Zha S, Alt FW, Downing JR, Mullighan CG, Look AT.

Blood. 2011 Oct 13;118(15):4169-73. doi: 10.1182/blood-2010-11-318873. Epub 2011 Aug 30.

44.

GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.

Meng X, Matlawska-Wasowska K, Girodon F, Mazel T, Willman CL, Atlas S, Chen IM, Harvey RC, Hunger SP, Ness SA, Winter SS, Wilson BS.

Leukemia. 2011 Jul;25(7):1135-46. doi: 10.1038/leu.2011.50. Epub 2011 Apr 15.

45.

Mammillothalamic tract lesions disrupt dead reckoning in the rat.

Winter SS, Wagner SJ, McMillin JL, Wallace DG.

Eur J Neurosci. 2011 Jan;33(2):371-81. doi: 10.1111/j.1460-9568.2010.07504.x. Epub 2010 Dec 7.

PMID:
21138488
46.

Navigating with fingers and feet: analysis of human (Homo sapiens) and rat (Rattus norvegicus) movement organization during nonvisual spatial tasks.

Wallace DG, Köppen JR, Jones JL, Winter SS, Wagner SJ.

J Comp Psychol. 2010 Nov;124(4):381-94. doi: 10.1037/a0020546.

PMID:
20836594
47.

Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.

Gutierrez A, Dahlberg SE, Neuberg DS, Zhang J, Grebliunaite R, Sanda T, Protopopov A, Tosello V, Kutok J, Larson RS, Borowitz MJ, Loh ML, Ferrando AA, Winter SS, Mullighan CG, Silverman LB, Chin L, Hunger SP, Sallan SE, Look AT.

J Clin Oncol. 2010 Aug 20;28(24):3816-23. doi: 10.1200/JCO.2010.28.3390. Epub 2010 Jul 19.

48.

Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

Gutierrez A, Sanda T, Ma W, Zhang J, Grebliunaite R, Dahlberg S, Neuberg D, Protopopov A, Winter SS, Larson RS, Borowitz MJ, Silverman LB, Chin L, Hunger SP, Jamieson C, Sallan SE, Look AT.

Blood. 2010 Apr 8;115(14):2845-51. doi: 10.1182/blood-2009-07-234377. Epub 2010 Feb 1.

49.

Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.

Sanda T, Li X, Gutierrez A, Ahn Y, Neuberg DS, O'Neil J, Strack PR, Winter CG, Winter SS, Larson RS, von Boehmer H, Look AT.

Blood. 2010 Mar 4;115(9):1735-45. doi: 10.1182/blood-2009-07-235143. Epub 2009 Dec 9.

50.

IKK inhibitor bay 11-7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts.

Meng X, Martinez MA, Raymond-Stintz MA, Winter SS, Wilson BS.

Br J Haematol. 2010 Feb;148(3):487-90. doi: 10.1111/j.1365-2141.2009.07988.x. Epub 2009 Dec 1. No abstract available.

PMID:
19958360

Supplemental Content

Loading ...
Support Center